Literature DB >> 23176175

High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin.

A Mireille Baart1, Paulus A H van Noord, Yvonne Vergouwe, Karel G M Moons, Dorine W Swinkels, Erwin T Wiegerinck, Wim L A M de Kort, Femke Atsma.   

Abstract

BACKGROUND: Blood donors that meet the hemoglobin (Hb) criteria for donation may have undetected subclinical iron deficiency. The aim of this study was to assess the prevalence of subclinical iron deficiency in whole blood donors with Hb levels above cutoff levels for donation by measuring zinc protoporphyrin (ZPP) levels. In addition, prevalence rates based on other iron variables were assessed for comparison. STUDY DESIGN AND METHODS: The study population comprised 5280 Dutch whole blood donors, who passed the Hb criteria for donation. During donor screening, Hb levels were measured in capillary samples (finger prick), and venous blood samples were taken for measurements of ZPP and other iron variables. These variables included ferritin, transferrin saturation, soluble transferrin receptor (sTfR), hepcidin, red blood cell mean corpuscular volume (MCV), and mean cell Hb (MCH).
RESULTS: With a ZPP cutoff level of at least 100 μmol/mol heme, subclinical iron deficiency was present in 6.9% of male donors and in 9.8% of female donors. Based on other iron variables, iron deficiency was also observed. Prevalence rates ranged from 4.8% (based on transferrin saturation) to 27.4% (based on hepcidin concentration) in men and from 5.6% (based on sTfR concentration) to 24.7% (based on hepcidin concentration) in women.
CONCLUSION: Results from this study showed that subclinical iron deficiency is prevalent among blood donors that meet the Hb criteria for blood donation, based on ZPP levels and on other iron variables. This finding needs attention because these donors are at increased risk of developing iron deficiency affecting Hb formation and other cellular processes.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23176175     DOI: 10.1111/j.1537-2995.2012.03956.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  15 in total

1.  Iron-deficient erythropoiesis in blood donors and red blood cell recovery after transfusion: initial studies with a mouse model.

Authors:  Sheila Bandyopadhyay; Gary M Brittenham; Richard O Francis; James C Zimring; Eldad A Hod; Steven L Spitalnik
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

2.  Oral iron supplementation after blood donation: a randomized clinical trial.

Authors:  Joseph E Kiss; Donald Brambilla; Simone A Glynn; Alan E Mast; Bryan R Spencer; Mars Stone; Steven H Kleinman; Ritchard G Cable
Journal:  JAMA       Date:  2015-02-10       Impact factor: 56.272

3.  Blood donors' physical characteristics are associated with pre- and post-donation symptoms - Donor InSight.

Authors:  Katja Van Den Hurk; Karlijn Peffer; Karin Habets; Femke Atsma; Pieternel C M Pasker-de Jong; Paulus A H Van Noord; Ingrid J T Veldhuizen; Wim L A M De Kort
Journal:  Blood Transfus       Date:  2016-07-12       Impact factor: 3.443

4.  Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy.

Authors:  Walter Bialkowski; Joseph E Kiss; David J Wright; Ritchard Cable; Rebecca Birch; Pam D'Andrea; Barbara J Bryant; Bryan R Spencer; Alan E Mast
Journal:  Am J Hematol       Date:  2017-06-09       Impact factor: 10.047

5.  Iron supplementation limits the deleterious effects of repeated blood donation on endurance sport performance but not on iron status.

Authors:  Barbara Pachikian; Damien Naslain; Nicolas Benoit; Romain Brebels; Kristin Van Asch; Veerle Compernolle; Philippe Vandekerckhove; Louise Deldicque
Journal:  Blood Transfus       Date:  2020-07-22       Impact factor: 3.443

6.  A non-invasive strategy for haemoglobin screening of blood donors.

Authors:  Pasqualepaolo Pagliaro; Annarita Belardinelli; Viana Boko; Petar Salamon; Silvia Manfroi; Pier Luigi Tazzari
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

7.  Hepcidin/Ferritin Quotient Helps to Predict Spontaneous Recovery from Iron Loss following Blood Donation.

Authors:  Ramin Lotfi; Christine Kroll; Dietmar Plonné; Bernd Jahrsdörfer; Hubert Schrezenmeier
Journal:  Transfus Med Hemother       Date:  2015-11-03       Impact factor: 3.747

Review 8.  Blood donor iron status: are we bleeding them dry?

Authors:  Bryan Spencer
Journal:  Curr Opin Hematol       Date:  2013-11       Impact factor: 3.284

9.  Donor Iron Deficiency Study (DIDS): protocol of a study to test whether iron deficiency in blood donors affects red blood cell recovery after transfusion.

Authors:  Zachary C Bitan; Alice Zhou; Donald J McMahon; Debra Kessler; Beth H Shaz; Elise Caccappolo; Joseph Schwartz; Richard O Francis; Gary M Brittenham; Steven L Spitalnik; Eldad A Hod
Journal:  Blood Transfus       Date:  2019-07       Impact factor: 3.443

10.  Blood donor selection in European Union directives: room for improvement.

Authors:  Wim De Kort; Wolfgang Mayr; Christof Jungbauer; Tomislav Vuk; Riin Kullaste; Erhard Seifried; Giuliano Grazzini; Jeroen De Wit; Gilles Folléa
Journal:  Blood Transfus       Date:  2015-10-05       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.